Blueprint Medicines Corp (NASDAQ:BPMC)
| 100.98 Delayed Data As of Jan 15 |  -1.53 / -1.49%Today’s Change | 43.29 Today|||52-Week Range 125.61 | -9.96% Year-to-Date |
Latest BPMC News | Press Releases
| Orchard (ORTX) Gets FDA's RMAT Status for Gene Therapy in MLD Jan 15 / Zacks.com - Paid Partner Content | 3 Biotech Stocks Worth Adding to Your Portfolio in 2021 Jan 08 / Zacks.com - Paid Partner Content |
| Acorda (ACOR) Soars on Sale of Manufacturing Unit for Inbrija Jan 14 / Zacks.com - Paid Partner Content | Genmab (GMAB) Begins Phase III Study on Cervical Cancer Drug Jan 05 / Zacks.com - Paid Partner Content |
| 3 Biotech Stocks Poised to Outperform Amid Coronavirus Pandemic Jan 13 / Zacks.com - Paid Partner Content | Axsome's (AXSM) Migraine Drug Shows Long-Term Safety in Study Jan 04 / Zacks.com - Paid Partner Content |
| Infrastructure and Energy Alternatives, Carrols Restaurant, Moderna, Blueprint Medicines and Halozyme Therapeutics highlighted as Zacks Bull and Bear of the Day Jan 11 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 102.51 |
| Today’s open | 102.74 |
| Day’s range | 100.65 - 102.74 |
| Volume | 17,505 |
| Average volume (3 months) | 502,903 |
| Market cap | $5.6B |
Data as of 3:58pm ET, 01/15/2021
Growth & Valuation
| Earnings growth (last year) | -34.76% |
| Earnings growth (this year) | +175.53% |
| Earnings growth (next 5 years) | +34.00% |
| Revenue growth (last year) | +49.39% |
| P/E ratio | 17.2 |
| Price/Sales | 57.61 |
| Price/Book | 10.69 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EBSEmergent BioSolution... | +0.24 | +0.23% |
| ---- | ||
| EIDXEidos Therapeutics I... | -2.00 | -1.56% |
| HALOHalozyme Therapeutic... | +0.39 | +0.83% |
Data as of 4:00pm ET, 01/15/2021
Financials
| Next reporting date | March 5, 2021 |
| EPS forecast (this quarter) | -$1.60 |
| Annual revenue (last year) | $66.5M |
| Annual profit (last year) | -$347.7M |
| Net profit margin | -522.75% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
